PRIVISCL Privi Speciality Chemicals Q1 FY27 results (Apr–Jun 2026) and concall
Privi Speciality Chemicals Limited reported a strong Q1 FY27 with consolidated total income growing 20.01% YoY to ₹681.42 crores and PAT increasing to ₹83.2 crores. EBITDA margins remained robust at 24.58%, with management expecting them to sustain around 25%. The company is progressing with its capacity expansion plans, with Phase-1 commercialization imminent, and has filed the merger scheme with NCLT, targeting completion within FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 6.2%, net profit up 21.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 518 | 498 | 581 | 566 | 656 +27% | 573 +15% | 660 +14% | 601 +6% |
| EBITDA | 111 | 111 | 127 | 136 | 184 +66% | 155 +40% | 182 +43% | 146 +7% |
| Net profit | 47 | 44 | 66 | 69 | 100 +113% | 86 +95% | 103 +56% | 84 +22% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
